DNTH
Dianthus Therapeutics Inc.
82.40$
-0.1%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -891.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +442.1% | +3.9% | +3.7% | +4.5% | -32.8% | +70.5% | -25.6% | +0.0% | -2.0% | -21.6% | -109.2% | – | |
| – | -38.4% | +180.3% | +52.4% | +23.8% | +2.0% | +35.7% | +7.4% | +1.5% | +3.2% | +77.4% | +12.2% | – | |
| – | -115.3% | – | – | +799.3% | -116.2% | – | – | -6.5% | +337.2% | -82.2% | -326.2% | – | |
| – | -93.1% | +220.0% | -46.9% | +47.1% | +24.0% | -22.6% | +91.7% | -89.1% | +2,660.0% | -92.8% | +1,710.0% | – | |
| – | -51.2% | -33.1% | – | -22,286.8% | -91.1% | – | +78.8% | -861.1% | – | -460.1% | +257.2% | – | |
| – | – | – | – | – | – | – | – | – | – | -62.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -103.2% | – | -101.0% | – | +13,304.1% | -99.6% | +252.8% | +48,229.8% | -98.2% | +15,042.5% | -98.6% | – | |
| – | -126.4% | – | -107.9% | – | – | – | – | +1,267.6% | -111.5% | – | -189.7% | – | |
| – | -822.5% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.